Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group.

RPEP-047622020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group.
Published In:
Annals of oncology : official journal of the European Society for Medical Oncology, 31(8), 978-990 (2020)
Database ID:
RPEP-04762

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-04762·https://rethinkpeptides.com/research/RPEP-04762

APA

De Mattos-Arruda, L; Vazquez, M; Finotello, F; Lepore, R; Porta, E; Hundal, J; Amengual-Rigo, P; Ng, C K Y; Valencia, A; Carrillo, J; Chan, T A; Guallar, V; McGranahan, N; Blanco, J; Griffith, M. (2020). Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group.. Annals of oncology : official journal of the European Society for Medical Oncology, 31(8), 978-990. https://doi.org/10.1016/j.annonc.2020.05.008

MLA

De Mattos-Arruda, L, et al. "Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group.." Annals of oncology : official journal of the European Society for Medical Oncology, 2020. https://doi.org/10.1016/j.annonc.2020.05.008

RethinkPeptides

RethinkPeptides Research Database. "Neoantigen prediction and computational perspectives towards..." RPEP-04762. Retrieved from https://rethinkpeptides.com/research/de-2020-neoantigen-prediction-and-computational

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.